Hackettstown, NJ, United States of America

Daniel Coughlin

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Hypnion, Inc., Kinex Pharmaceuticals, LLC, Colucid Pharmaceuticals, Inc.. Active years: 2009-2012.

USPTO Granted Patents = 7 

% Patents Active = 42.9

 

 

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 74(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Journey of Daniel Coughlin

Introduction: Daniel Coughlin, a talented inventor hailing from Hackettstown, NJ, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Daniel Coughlin's latest patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and convenience, as well as a cutting-edge medical device designed to improve patient outcomes in the healthcare industry.

Career Highlights: Throughout his illustrious career, Daniel Coughlin has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His work has not only earned him numerous patents but has also garnered acclaim from industry experts and peers alike.

Collaborations: Daniel Coughlin has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly with teams of experts from diverse backgrounds has been instrumental in the success of his projects.

Conclusion: In conclusion, Daniel Coughlin stands as a shining example of creativity and ingenuity in the field of innovation. His passion for creating cutting-edge solutions to real-world problems continues to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…